BioCentury | Jun 3, 2017
Finance

Clever chemistry

...million) seed round followed in 2015 from Merck Ventures, Aglaia Oncology Fund, Novo Seeds and EVA Basel...
BioCentury | Dec 21, 2015
Financial News

Inthera Bioscience completes venture financing

...Venture financing Raised: EUR3.4 million ($3.7 million) Investors: MS Ventures; Aglaia Oncology Fund; Novo Seeds; EVA Basel WIR...
BioCentury | Jul 27, 2015
Financial News

Memo Therapeutics completes venture financing

...2015-07-22 Type: Venture financing Raised: CHF2.3 million ($2.4 million) Investors: Redalpine Venture Partners; Zuercher Kantonalbank; EVA Basel WIR...
Items per page:
1 - 3 of 3
BioCentury | Jun 3, 2017
Finance

Clever chemistry

...million) seed round followed in 2015 from Merck Ventures, Aglaia Oncology Fund, Novo Seeds and EVA Basel...
BioCentury | Dec 21, 2015
Financial News

Inthera Bioscience completes venture financing

...Venture financing Raised: EUR3.4 million ($3.7 million) Investors: MS Ventures; Aglaia Oncology Fund; Novo Seeds; EVA Basel WIR...
BioCentury | Jul 27, 2015
Financial News

Memo Therapeutics completes venture financing

...2015-07-22 Type: Venture financing Raised: CHF2.3 million ($2.4 million) Investors: Redalpine Venture Partners; Zuercher Kantonalbank; EVA Basel WIR...
Items per page:
1 - 3 of 3